PG
ELV icon

Pendal Group’s Elevance Health ELV Stock Holding History

Pendal Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$222M Sell
432,785
-38,588
-8% -$19.6M 1.92% 11
2022
Q3 		$214M Buy
471,373
+39,549
+9% +$18.9M 2.08% 11
2022
Q2 		$208M Buy
431,824
+209,746
+94% +$104M 2.05% 11
2022
Q1 		$109M Buy
222,078
+44,238
+25% +$20.2M 0.9% 43
2021
Q4 		$82.4M Sell
177,840
-66,216
-27% -$27.9M 0.66% 49
2021
Q3 		$91M Buy
244,056
+1,328
+0.5% +$505K 0.75% 51
2021
Q2 		$92.7M Buy
242,728
+239,378
+7,146% +$91.5M 0.85% 47
2021
Q1 		$1.2M Sell
3,350
-922
-22% -$297K 0.01% 292
2020
Q4 		$1.37M Sell
4,272
-12,121
-74% -$3.72M 0.01% 254
2020
Q3 		$4.4M Buy
16,393
+3,469
+27% +$933K 0.05% 105
2020
Q2 		$3.4M Buy
12,924
+1,603
+14% +$428K 0.05% 130
2020
Q1 		$2.57M Sell
11,321
-10,358
-48% -$2.82M 0.04% 138
2019
Q4 		$6.55M Buy
21,679
+19,872
+1,100% +$5.47M 0.09% 111
2019
Q3 		$434K Sell
1,807
-35,920
-95% -$9.84M 0.01% 366
2019
Q2 		$10.6M Sell
37,727
-6,856
-15% -$1.87M 0.15% 72
2019
Q1 		$12.8M Hold
44,583
– – 0.18% 68
2018
Q4 		$11.7M Buy
44,583
+9,727
+28% +$2.67M 0.19% 76
2018
Q3 		$9.55M Sell
34,856
-1,809
-5% -$470K 0.13% 94
2018
Q2 		$8.73M Sell
36,665
-8,989
-20% -$2.08M 0.11% 121
2018
Q1 		$10M Hold
45,654
– – 0.13% 114
2017
Q4 		$10.3M Buy
45,654
+10,109
+28% +$2.15M 0.13% 117
2017
Q3 		$6.76M Sell
35,545
-7,370
-17% -$1.4M 0.09% 151
2017
Q2 		$8.07M Buy
+42,915
New +$7.71M 0.12% 134

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Pendal Group's ELV Position: Q4 2022 in Review

Pendal Group reduced its Elevance Health (ELV) stake by 8.2% in Q4 2022, selling an estimated $19.6M and leaving 432,785 shares worth $222M. The position accounts for 1.92% of the portfolio, ranked #11.

Pendal Group first reported a position in ELV in Q2 2017 and has held it in 23 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Pendal Group held 432,785 shares of Elevance Health worth $222M as of Q4 2022.
  • Pendal Group sold 38,588 Elevance Health shares in Q4 2022, an estimated $19.6M.
  • Elevance Health made up 1.92% of Pendal Group's portfolio in Q4 2022, its #11 holding.
  • Pendal Group first reported a position in Elevance Health in Q2 2017 and has held it in 23 quarters since.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.